CN105521341A - Traditional Chinese medicine for treating chronic bronchitis combined emphysema - Google Patents
Traditional Chinese medicine for treating chronic bronchitis combined emphysema Download PDFInfo
- Publication number
- CN105521341A CN105521341A CN201610071739.0A CN201610071739A CN105521341A CN 105521341 A CN105521341 A CN 105521341A CN 201610071739 A CN201610071739 A CN 201610071739A CN 105521341 A CN105521341 A CN 105521341A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- radix
- chronic bronchitis
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating chronic bronchitis combined emphysema. The traditional Chinese medicine is prepared from the following raw medicinal materials at a certain weight ratio: roasted herba ephedra, ginkgo, apricot kernels, perilla seeds, pinellia ternata, flos farfarae, fructus aurantii, platycodon grandiflorum, semen lepidii, radix scutellariae, the root bark of white mulberry, gypsum, rhizoma phragmitis, radix ophiopogonis, the fruits of Chinese magnoliavine, red ginseng, roasted white atractylodes rhizome, poria cocos and raw licorice root. The traditional Chinese medicine is easy to prepare, low in cost, wide in medicinal material resource, convenient to use, rapid in taking effect, high in cure rate, and free of any toxic and side effects; the effective rate is 100%, and the cure rate is 98%.
Description
Technical field
the present invention relates to one to treat chronic bronchitis and merge emophysematous Chinese medicine, belong to technical field of Chinese medicines.
Background technology
chronic bronchitis is modal respiratory tract disease, annual winter attack, and cough more than 3 months, does not heal for many years, and then develop into emphysema, pulmonary heart disease continuously.
primary disease belongs to the categories such as " cough ", " the syndrome of dyspnea " of the traditional Chinese medical science.Cardinal symptom for coughing, pant, abundant expectoration, uncomfortable in chest, breathe hard.Sick position is mainly at lung and kidney, relevant with liver, spleen.Basic pathogenesis is that diseases caused by exogenous pathogenic factor or internal injury cause impairment of dispersing and descending function of the lung, abnormal rising of lung-QI, gas without lead, kidney loses and takes the photograph and receive.Therapeutic Principle is based on dispersing and lowering lung-QI, asthma-relieving phlegm-reducing, clearing away heat and expelling pathogen in the exterior, invigorating the spleen and replenishing QI.
Summary of the invention
the object of the invention is the deficiency in order to solve above-mentioned technology, providing a kind of good effect, short treating period, cure rate high, effectively can treat chronic bronchitis and merge emophysematous Chinese medicine.
for achieving the above object, one is treated chronic bronchitis and is merged emophysematous Chinese medicine, it is characterized in that material medicine and weight proportion are: Herba Ephedrae (processed) 10-12g, Semen Ginkgo 10-12g, Semen Armeniacae Amarum 10-12g, Fructus Perillae 10-12g, Rhizoma Pinelliae 10-12g, Flos Farfarae 10-12g, Fructus Aurantii 12-15g, Radix Platycodonis 12-15g, Semen Lepidii (Semen Descurainiae) 15-20g, Radix Scutellariae 10-12g, Cortex Mori 15-18g, Gypsum Fibrosum 25-30g, Rhizoma Phragmitis 25-30g, Radix Ophiopogonis 15-20g, Fructus Schisandrae Chinensis 6-9g, Radix Ginseng Rubra 10-12g, Rhizoma Atractylodis Macrocephalae (parched) 10-15g, Poria 10-15g, Radix Glycyrrhizae 6-9g.
traditional Chinese medicine of the present invention is simple, and cost is low, and medicine source is wide, easy to use, and curative effect is fast, and cure rate is high, without any side effects.
pharmacology analysis: in side's medicine of the present invention, Herba Ephedrae (processed) depressed lung-energy dispersing, holds concurrently and separates pathogenic factor in the exterior; Semen Ginkgo astringing lung-QI and relieving cough, resolving phlegm and relieving asthma, two medicine compatibilities, one loose one receives, and both can strengthen the merit of relieving cough and asthma, again unlikely consumption impairing the lung gas, be principal agent altogether.Semen Armeniacae Amarum, Fructus Perillae, the Rhizoma Pinelliae, Flos Farfarae lowering the adverse-rising QI to resolve phlegm, strengthen antiasthmatic effect; Radix Platycodonis, Fructus Aurantii match, one rise and one drop, the chest stuffiness relieving profit diaphragm, and dispersing and lowering lung-QI is held concurrently relieving cough and resolving phlegm; Semen Lepidii (Semen Descurainiae) eliminating the pathogens from the lung row water, the therapeutic method to keep the adverse QI flowing downwards is relievingd asthma, and has cardiotonic, is accessory drugs altogether.Radix Scutellariae joins Cortex Mori, Gypsum Fibrosum, Rhizoma Phragmitis eliminating heat from the lung, with relieving cough and asthma; Replenishing YIN and removing heat Radix Ophiopogonis is to promote the production of body fluid; Fructus Schisandrae Chinensis supplementing QI for promoting the production of body fluid, the kidney invigorating is nourished heart, and convergence lung qi is adjuvant drug altogether.Radix Ginseng Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae invigorating the spleen and replenishing QI, altogether for making medicine.All medicines share, and play dispersing and lowering lung-QI altogether, asthma-relieving phlegm-reducing, clearing away heat and expelling pathogen in the exterior, the merit of reinforcing spleen and kidney of holding concurrently.
form of Chinese drug of the present invention is decoction, is decocted in water for oral dose, and every day, potion, decocted twice.Head is decocted and is added cold water 1000ml, soaks two hours, and change slow fire after intense fire boils and continue and decoct 30 minutes, extracting juice is about 200ml; Two decoct heating water, change that slow fire is continuous decocts 50 minutes after intense fire boils, and extracting juice is about 200ml.Two decoct the mixing of gained medicine juice sooner or later respectively takes 200ml, warm water delivery service in two hours after meal, and period in a medicine avoids pungent food cold and cool food.
detailed description of the invention:
embodiment 1: one is treated chronic bronchitis and merged emophysematous Chinese medicine is made up of following raw materials according medicine and weight proportion: Herba Ephedrae (processed) 10-12g, Semen Ginkgo 10-12g, Semen Armeniacae Amarum 10-12g, Fructus Perillae 10-12g, Rhizoma Pinelliae 10-12g, Flos Farfarae 10-12g, Fructus Aurantii 12-15g, Radix Platycodonis 12-15g, Semen Lepidii (Semen Descurainiae) 15-20g, Radix Scutellariae 10-12g, Cortex Mori 15-18g, Gypsum Fibrosum 25-30g, Rhizoma Phragmitis 25-30g, Radix Ophiopogonis 15-20g, Fructus Schisandrae Chinensis 6-9g, Radix Ginseng Rubra 10-12g, Rhizoma Atractylodis Macrocephalae (parched) 10-15g, Poria 10-15g, Radix Glycyrrhizae 6-9g.
embodiment 2: one is treated chronic bronchitis and merged emophysematous Chinese medicine, wherein the preferred weight proportioning of various material medicine is: Herba Ephedrae (processed) 10g, Semen Ginkgo 10g, Semen Armeniacae Amarum 10g, Fructus Perillae 10g, Rhizoma Pinelliae 10g, Flos Farfarae 10g, Fructus Aurantii 12g, Radix Platycodonis 12g, Semen Lepidii (Semen Descurainiae) 15g, Radix Scutellariae 10g, Cortex Mori 15g, Gypsum Fibrosum 25g, Rhizoma Phragmitis 25g, Radix Ophiopogonis 15g, Fructus Schisandrae Chinensis 6g, Radix Ginseng Rubra 10g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Poria 10g, Radix Glycyrrhizae 6g.
clinical efficacy is summed up:
one, physical data:
the example overwhelming majority is cured the disease for gerontal patient by institute, and women is more than male.Minimum 50 years old of age, maximum 70 years old.The shortest person of the course of disease 5 years, most elder 30 years.
two, diagnostic criteria:
the cough of recurrent exerbation, expectoration, companion pants, ill at least 3 months every year, namely diagnosable after the eliminating heart, other chronic diseases of lung and chronic pharyngitis.
three, curative effect determinate standard:
cure: clinical symptom disappearance, hemogram chemical examination is normal.
take a turn for the better: only show slight cough, pant, hemogram chemical examination is normal.
four, therapeutic effect:
taking medicine 10 days is a course for the treatment of, and the lighter takes medicine and is namely clearly better a course for the treatment of, recovery from illness two courses for the treatment of, and severe one is taken medicine and was clearly better two courses for the treatment of, recovery from illness three courses for the treatment of, effective percentage 100%, cure rate 98%.
five, model case:
1, grandson's ××, female, 60 years old, in January, 2014 went to a doctor.Repeatedly cough with asthma, uncomfortable in chest, feel suffocated more than 10 year, increase the weight of 1 month, be diagnosed as " chronic bronchitis emphysema ", once Multiple Hospitalization treatment, effect is not satisfactory.Requirement takes traditional Chinese medicine treatment, gives the treatment of this decoction, takes 10 doses, and cough with asthma, feeling suffocated alleviates, following the service 10 doses, and symptom disappears substantially, then takes 10 doses, and all diseases disappear and fully recover, and follow up a case by regular visits to and do not recur so far again.
, Lee's ××, female, 70 years old, in December, 2012 was gone to a doctor.Patient suffers from " chronic bronchitis emphysema " 20 years, and annual winter increases the weight of, and all needs hospitalization could alleviate, and recently bring out because of flu again and increase the weight of, cough is panted, and requirement takes traditional Chinese medicine treatment.Give Chinese medicine of the present invention and take 10 days, all diseases subtract greatly, continue to take 10 doses, cough transference cure, and diet and life are substantially as ordinary person.Require to take this treatment by Chinese herbs when patient catches a cold every winter over 2 years, control symptom early, prevention of recurrence.
Claims (1)
1. treat chronic bronchitis merge an emophysematous Chinese medicine, it is characterized in that material medicine and weight proportion are: Herba Ephedrae (processed) 10-12g, Semen Ginkgo 10-12g, Semen Armeniacae Amarum 10-12g, Fructus Perillae 10-12g, Rhizoma Pinelliae 10-12g, Flos Farfarae 10-12g, Fructus Aurantii 12-15g, Radix Platycodonis 12-15g, Semen Lepidii (Semen Descurainiae) 15-20g, Radix Scutellariae 10-12g, Cortex Mori 15-18g, Gypsum Fibrosum 25-30g, Rhizoma Phragmitis 25-30g, Radix Ophiopogonis 15-20g, Fructus Schisandrae Chinensis 6-9g, Radix Ginseng Rubra 10-12g, Rhizoma Atractylodis Macrocephalae (parched) 10-15g, Poria 10-15g, Radix Glycyrrhizae 6-9g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610071739.0A CN105521341A (en) | 2016-02-02 | 2016-02-02 | Traditional Chinese medicine for treating chronic bronchitis combined emphysema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610071739.0A CN105521341A (en) | 2016-02-02 | 2016-02-02 | Traditional Chinese medicine for treating chronic bronchitis combined emphysema |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105521341A true CN105521341A (en) | 2016-04-27 |
Family
ID=55764085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610071739.0A Withdrawn CN105521341A (en) | 2016-02-02 | 2016-02-02 | Traditional Chinese medicine for treating chronic bronchitis combined emphysema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105521341A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109260137A (en) * | 2018-11-30 | 2019-01-25 | 江苏贝塔仕生物科技有限公司 | It is a kind of can be with the formula of medicinal lipstick |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745060A (en) * | 2010-02-09 | 2010-06-23 | 姜晓红 | Chinese medicament for treating chronic bronchitis |
-
2016
- 2016-02-02 CN CN201610071739.0A patent/CN105521341A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101745060A (en) * | 2010-02-09 | 2010-06-23 | 姜晓红 | Chinese medicament for treating chronic bronchitis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109260137A (en) * | 2018-11-30 | 2019-01-25 | 江苏贝塔仕生物科技有限公司 | It is a kind of can be with the formula of medicinal lipstick |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526674A (en) | Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven | |
CN100478020C (en) | Stomatocase treating medicine | |
CN103784756A (en) | Traditional Chinese medicine composition for treating internal heat due to yin deficiency | |
CN101745060B (en) | Chinese medicament for treating chronic bronchitis | |
CN102198259A (en) | Chinese medicine composition for treating vomit | |
CN103948675A (en) | Traditional Chinese medicine for treating chronic rhinitis | |
CN103495020B (en) | Traditional Chinese medicine for treating diabetes | |
CN104352793A (en) | Traditional Chinese medicine preparation for treating gastrointestinal bleeding and preparation method thereof | |
CN101757516A (en) | Prescription of traditional Chinese medicine for treating infantile allergic asthma | |
CN100998825A (en) | Oral Chinese medicine for treating yin blood insufficiency type virus myocarditis | |
CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
CN104840577A (en) | Traditional Chinese medicine for treating pantalgia after childbirth | |
CN105521341A (en) | Traditional Chinese medicine for treating chronic bronchitis combined emphysema | |
CN103800689A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
CN103494983B (en) | Traditional Chinese medicine for treating influenza | |
CN105833084A (en) | Traditional Chinese medicine for treating oral ulcers | |
CN105796945A (en) | Traditional Chinese medicine for treating depression syndromes | |
CN105641419A (en) | Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer | |
CN104771660A (en) | Chinese traditional medicine preparation for treatment of gastric cancer and preparation method thereof | |
CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
CN104491816A (en) | Application of traditional Chinese medicinal composition in preparation of medicine for treating chronic gastroenteritis | |
CN103169865B (en) | Traditional Chinese medicine oral syrup for treating diabetes (diabetes mellitus) | |
CN102284023A (en) | Chinese medicinal composition for treating asthma | |
CN102309725B (en) | Traditional Chinese medicine preparation for treating hepatitis B cirrhosis and preparation method | |
CN105749243A (en) | Traditional Chinese medicine for treating coolness diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160427 |
|
WW01 | Invention patent application withdrawn after publication |